COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)

Srikanth Muppidi; Jeffrey T Guptill; Saiju Jacob; Yingkai Li; Maria E Farrugia; Amanda C Guidon; Jinny O Tavee; Henry Kaminski; James F Howard; Gary Cutter; Heinz Wiendl; Matthew B Maas; Isabel Illa; Renato Mantegazza; Hiroyuki Murai; Kimiaki Utsugisawa; Richard J Nowak; CARE-MG Study Group; John Vissing

doi:10.1016/S1474-4422(20)30413-0

COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)

Srikanth Muppidi, Jeffrey T Guptill, Saiju Jacob, Yingkai Li, Maria E Farrugia, Amanda C Guidon, Jinny O Tavee, Henry Kaminski, James F Howard, Gary Cutter, Heinz Wiendl, Matthew B Maas, Isabel Illa, Renato Mantegazza, Hiroyuki Murai, Kimiaki Utsugisawa, Richard J Nowak, CARE-MG Study Group, John Vissing (Member of study group)

Department of Neurology

Original language	English
Journal	The Lancet Neurology
Volume	19
Issue number	12
Pages (from-to)	970-971
Number of pages	2
ISSN	1474-4422
DOIs	https://doi.org/10.1016/S1474-4422(20)30413-0
Publication status	Published - Dec 2020

Keywords

COVID-19/diagnosis
Humans
Myasthenia Gravis/diagnosis
Registries
Risk Factors
SARS-CoV-2

Access to Document

10.1016/S1474-4422(20)30413-0

Cite this

Muppidi, S., Guptill, J. T., Jacob, S., Li, Y., Farrugia, M. E., Guidon, A. C., Tavee, J. O., Kaminski, H., Howard, J. F., Cutter, G., Wiendl, H., Maas, M. B., Illa, I., Mantegazza, R., Murai, H., Utsugisawa, K., Nowak, R. J., CARE-MG Study Group, & Vissing, J. (2020). COVID-19-associated risks and effects in myasthenia gravis (CARE-MG). The Lancet Neurology, 19(12), 970-971. https://doi.org/10.1016/S1474-4422(20)30413-0

Muppidi, S, Guptill, JT, Jacob, S, Li, Y, Farrugia, ME, Guidon, AC, Tavee, JO, Kaminski, H, Howard, JF, Cutter, G, Wiendl, H, Maas, MB, Illa, I, Mantegazza, R, Murai, H, Utsugisawa, K, Nowak, RJ, CARE-MG Study Group & Vissing, J 2020, 'COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)', The Lancet Neurology, vol. 19, no. 12, pp. 970-971. https://doi.org/10.1016/S1474-4422(20)30413-0

@article{7058ccd50a66459fa5e79297fb8a82f6,

title = "COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)",

keywords = "COVID-19/diagnosis, Humans, Myasthenia Gravis/diagnosis, Registries, Risk Factors, SARS-CoV-2",

author = "Srikanth Muppidi and Guptill, {Jeffrey T} and Saiju Jacob and Yingkai Li and Farrugia, {Maria E} and Guidon, {Amanda C} and Tavee, {Jinny O} and Henry Kaminski and Howard, {James F} and Gary Cutter and Heinz Wiendl and Maas, {Matthew B} and Isabel Illa and Renato Mantegazza and Hiroyuki Murai and Kimiaki Utsugisawa and Nowak, {Richard J} and {CARE-MG Study Group} and John Vissing",

year = "2020",

month = dec,

doi = "10.1016/S1474-4422(20)30413-0",

language = "English",

volume = "19",

pages = "970--971",

journal = "The Lancet Neurology",

issn = "1474-4422",

publisher = "The/Lancet Publishing Group",

number = "12",

}

TY - JOUR

T1 - COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)

AU - Muppidi, Srikanth

AU - Guptill, Jeffrey T

AU - Jacob, Saiju

AU - Li, Yingkai

AU - Farrugia, Maria E

AU - Guidon, Amanda C

AU - Tavee, Jinny O

AU - Kaminski, Henry

AU - Howard, James F

AU - Cutter, Gary

AU - Wiendl, Heinz

AU - Maas, Matthew B

AU - Illa, Isabel

AU - Mantegazza, Renato

AU - Murai, Hiroyuki

AU - Utsugisawa, Kimiaki

AU - Nowak, Richard J

AU - CARE-MG Study Group

A2 - Vissing, John

PY - 2020/12

Y1 - 2020/12

KW - COVID-19/diagnosis

KW - Humans

KW - Myasthenia Gravis/diagnosis

KW - Registries

KW - Risk Factors

KW - SARS-CoV-2

U2 - 10.1016/S1474-4422(20)30413-0

DO - 10.1016/S1474-4422(20)30413-0

M3 - Letter

C2 - 33212055

SN - 1474-4422

VL - 19

SP - 970

EP - 971

JO - The Lancet Neurology

JF - The Lancet Neurology

IS - 12

ER -